Results 21 to 30 of about 74,225 (263)
Clinical and Experimental Obstetrics & Gynecology, 2023 Background: The population of older women (≥70 years old) with triple-negative breast cancer (TNBC) is increasing, but there are few prognostic studies for these patients.
Chongwu He +7 more
doaj +1 more source
Luminescent iridium(III)-pyridyl based complexes: tumor inhibitory studies in 4T1 mammary carcinoma mice model [PDF]
Exploration of Drug ScienceAim: The iridium(III) [Ir(III)] complexes exhibit anticancer properties, and along with their photoluminescence properties, they can be employed as diagnostic agents. Hence, we have tried to evaluate both properties.
Natesan Sundarmurthy Karthikeyan +5 more
doaj +1 more source
PD-L1 expression in triple-negative breast cancer: a cross-sectional study in a Polish population
Polish Journal of Pathology, 2021 Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast carcinomas and represents an aggressive variant with a high mortality rate. PD-L1 is a protein that plays a pivotal role in suppressing the adaptive immune system.
Łukasz Szylberg +8 more
doaj +1 more source
Molecular & Cellular Oncology, 2020 Lipid and cholesterol reprogramming are often observed in specific cancer subtypes. We find that triple-negative breast cancers (TNBCs), but not estrogen receptor-positive (ER+) ones, adopt nuclear receptor RAR-related orphan receptor γ (RORγ) as their ...
Demin Cai, Xiong Zhang, Hong-Wu Chen
doaj +1 more source
Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
Cells, 2020 Triple-negative breast cancer (TNBC) stands out for its aggressiveness and accelerated rate of proliferation. Evidence shows that exercise may exert antitumorigenic effects, but the biochemical mechanisms underlying them remain unclear. Our objective was
Anderson Vulczak +5 more
doaj +1 more source
Frontiers in Bioscience-LandmarkAltered metabolism represents a fundamental difference between cancer cells and normal cells. Cancer cells have a unique ability to reprogram their metabolism by deviating their reliance from primarily oxidative phosphorylation (OXPHOS) to glycolysis, in
Erna Mitaishvili +6 more
doaj +1 more source
Frontiers in Bioscience-Landmark, 2022 Background: Disseminated tumor cells (DTCs) in bone marrow aspirates of patients with primary breast cancer may serve as independent prognostic markers associated with impaired survival.
Ivonne Nel +2 more
doaj +1 more source
Clinicopathologic Features of TNBC versus non-TNBC.
, 2014 Abbreviations: TNBC = triple negative breast carcinoma.Clinicopathologic Features of TNBC versus non-TNBC.
Gary Tozbikian (674932) +11 more
core +1 more source
Atezolizumab Treatment for TNBC-3
, 2021 Metabolic analysis of 5 progression disease (PD) TNBC ...
liu, K (via Mendeley Data), liu, karen
core +1 more source
Distribution of MSLN scores in TNBC versus non-TNBC.
, 2014 Abbreviations: MSLN = mesothelin; TNBC = triple negative breast carcinomas.Distribution of MSLN scores in TNBC versus non-TNBC.
Gary Tozbikian (674932) +11 more
core +1 more source